Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22463839 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cardiomyopathy in DMD: Lisinopril vs. Losartan
Conditions: Duchenne Muscular Dystrophy (DMD);   Cardiomyopathy
Interventions: Drug: Losartan;   Drug: Lisinopril

Indicates status has not been verified in more than two years